Ethical Concerns About Relapse Studies
Shamoo, Adil E.
Keay, Timothy J.
Cambridge Quarterly of Healthcare Ethics. 1996 Summer; 5(3): 373-386.
Our purpose in this focused literature review was to determine if questions about informed consent or protection from harm occur more commonly than in just one highlighted study at UCLA. First we assumed that all research subjects have certain rights -- derived from such basic bioethical principles as autonomy, nonmaleficence, and beneficence -- that must be respected during all research projects. These rights have been accepted and delineated to a large extent in the current Federal regulations (45 CFR 46). Second we assumed that research involving vulnerable patient populations -- and schizophrenic patients may be vulnerable because of their cognitive disorder -- deserves special ethical consideration and attention to the issues of informed consent and protection from harm as a result of experimentation. Therefore, we expected to find that researchers reported the detailed special attention to the process of informed consent and protection from harm in the studies involving possible relapse of symptoms in schizophrenic patients.
Autonomy; Beneficence; Competence; Conflict of Interest; Consent; Disclosure; Drugs; Editorial Policies; Empirical Research; Ethics; Ethics Committees; Harm; Human Experimentation; Informed Consent; Investigators; Literature; Nonmaleficence; Patients; Physicians; Psychoactive Drugs; Research; Research Design; Research Subjects; Researchers; Review; Rights; Risk; Risks and Benefits; Schizophrenia; Selection of Subjects; Withholding Treatment;
Showing items related by title, author, creator and subject.